These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 1838671)
1. Interleukin-1 (IL-1) and interleukin-1 receptor antagonist (IL-1ra). Conti P Ann Med Interne (Paris); 1991; 142(7):521-5. PubMed ID: 1838671 [No Abstract] [Full Text] [Related]
2. The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist. Barak V; Peritt D; Flechner I; Yanai P; Halperin T; Treves AJ; Dinarello CA Lymphokine Cytokine Res; 1991 Dec; 10(6):437-42. PubMed ID: 1839505 [TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073 [TBL] [Abstract][Full Text] [Related]
4. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937 [TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350 [TBL] [Abstract][Full Text] [Related]
6. Causal links between brain cytokines and experimental febrile convulsions in the rat. Heida JG; Pittman QJ Epilepsia; 2005 Dec; 46(12):1906-13. PubMed ID: 16393156 [TBL] [Abstract][Full Text] [Related]
7. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer. Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196 [TBL] [Abstract][Full Text] [Related]
8. The interleukin-1 receptor antagonist and its delivery by gene transfer. Evans CH; Robbins PD Receptor; 1994; 4(1):9-15. PubMed ID: 8038709 [TBL] [Abstract][Full Text] [Related]
9. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis. Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744 [TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits. Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317 [TBL] [Abstract][Full Text] [Related]
12. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. O'Nualláin EM; Puri P; Mealy K; Reen DJ Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873 [TBL] [Abstract][Full Text] [Related]
13. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha. Higgins GC; Wu Y; Postlethwaite AE J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999 [TBL] [Abstract][Full Text] [Related]
14. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Eisenberg SP; Evans RJ; Arend WP; Verderber E; Brewer MT; Hannum CH; Thompson RC Nature; 1990 Jan; 343(6256):341-6. PubMed ID: 2137201 [TBL] [Abstract][Full Text] [Related]
15. Cytokine expression in the placenta. The role of interleukin 1 and interleukin 1 receptor antagonist expression in chorioamnionitis and parturition. Baergen R; Benirschke K; Ulich TR Arch Pathol Lab Med; 1994 Jan; 118(1):52-5. PubMed ID: 7506905 [TBL] [Abstract][Full Text] [Related]
16. The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Dower SK; Kronheim SR; Hopp TP; Cantrell M; Deeley M; Gillis S; Henney CS; Urdal DL Nature; 1986 Nov 20-26; 324(6094):266-8. PubMed ID: 2946959 [TBL] [Abstract][Full Text] [Related]
18. Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production. Welsh N; Bendtzen K; Welsh M J Clin Invest; 1995 Apr; 95(4):1717-22. PubMed ID: 7706480 [TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health. Matsukawa A; Fukumoto T; Maeda T; Ohkawara S; Yoshinaga M Cytokine; 1997 May; 9(5):307-15. PubMed ID: 9195129 [TBL] [Abstract][Full Text] [Related]
20. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. Burger D; Chicheportiche R; Giri JG; Dayer JM J Clin Invest; 1995 Jul; 96(1):38-41. PubMed ID: 7615809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]